z-logo
open-access-imgOpen Access
Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion
Author(s) -
Thomas Delong,
Timothy A. Wiles,
Rocky L. Baker,
Brenda Bradley,
Gene Barbour,
Richard Reisdorph,
Michael Armstrong,
Roger Powell,
Nichole Reisdorph,
Nitesh Kumar,
Colleen M. Elso,
Megan DeNicola,
Rita Bottino,
Alvin C. Powers,
David M. Harlan,
Sally C. Kent,
Stuart I. Mannering,
Kathryn Haskins
Publication year - 2016
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aad2791
Subject(s) - autoimmunity , peptide , epitope , pancreatic islets , fusion protein , type 1 diabetes , biology , islet , antigen , insulin , chemistry , microbiology and biotechnology , immunology , biochemistry , diabetes mellitus , antibody , endocrinology , recombinant dna , gene
T cell-mediated destruction of insulin-producing β cells in the pancreas causes type 1 diabetes (T1D). CD4 T cell responses play a central role in β cell destruction, but the identity of the epitopes recognized by pathogenic CD4 T cells remains unknown. We found that diabetes-inducing CD4 T cell clones isolated from nonobese diabetic mice recognize epitopes formed by covalent cross-linking of proinsulin peptides to other peptides present in β cell secretory granules. These hybrid insulin peptides (HIPs) are antigenic for CD4 T cells and can be detected by mass spectrometry in β cells. CD4 T cells from the residual pancreatic islets of two organ donors who had T1D also recognize HIPs. Autoreactive T cells targeting hybrid peptides may explain how immune tolerance is broken in T1D.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom